WVP
IMMU

Worth Venture Partners’s Immunomedics Inc IMMU Stock Holding History

Worth Venture Partners’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-128,100
Closed -$999K – 122
2018
Q4 		$999K Buy
+128,100
New +$2.54M 0.76% 27
2018
Q3 		– Sell
-187,100
Closed -$3.2M – 194
2018
Q2 		$3.2M Sell
187,100
-45,800
-20% -$920K 2.64% 11
2018
Q1 		$1.98M Buy
232,900
+42,800
+23% +$699K 1.72% 17
2017
Q4 		$1.93M Buy
190,100
+111,800
+143% +$1.32M 2.13% 14
2017
Q3 		$654K Buy
78,300
+20,000
+34% +$199K 0.57% 39
2017
Q2 		$198K Buy
58,300
+44,700
+329% +$314K 0.17% 87
2017
Q1 		$17K Buy
+13,600
New +$68.9K 0.02% 122

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return